SCHEMBL1879462

SCHEMBL1879462

CCC(N)CCCC(=O)O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPEP Q07075 5/20 0.63
ALDH1A1 P00352 3/20 0.62
GABRP O00591 2/20 0.48
GABRD O14764 2/20 0.48
GABRA1 P14867 2/20 0.48
GABRB1 P18505 2/20 0.48
GABRG2 P18507 2/20 0.48
GABRB3 P28472 2/20 0.48
GABRA5 P31644 2/20 0.48
GABRA3 P34903 2/20 0.48
GABRA2 P47869 2/20 0.48
GABRB2 P47870 2/20 0.48
GABRA4 P48169 2/20 0.48
GABRE P78334 2/20 0.48
GABRA6 Q16445 2/20 0.48
GABRG1 Q8N1C3 2/20 0.48
GABRG3 Q99928 2/20 0.48
GABRQ Q9UN88 2/20 0.48
AKR1B1 P15121 1/20 0.46
ANPEP P15144 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10990632 0.98 ENPEP (0.61) ENPEPALDH1A1GABRPGABRDGABRA1
Iodide SCHEMBL28846315 0.98 ENPEP (0.61) ENPEPALDH1A1GABRPGABRDGABRA1
SCHEMBL134587 0.93 ALDH1A1 (0.71) ENPEPALDH1A1AKR1B1GPR84PPARG
SCHEMBL6903110 0.93 ALDH1A1 (0.71) ENPEPALDH1A1AKR1B1GPR84PPARG
SCHEMBL1883310 0.91 ALDH1A1 (0.75) ENPEPALDH1A1GPR84PPARGPPARD
SCHEMBL1874205 0.91 ALDH1A1 (0.75) ENPEPALDH1A1GPR84PPARGPPARD
SCHEMBL1879117 0.91 ALDH1A1 (0.75) ENPEPALDH1A1GPR84PPARGPPARD
SCHEMBL1879196 0.91 ALDH1A1 (0.75) ENPEPALDH1A1GPR84PPARGPPARD
SCHEMBL1873944 0.91 ALDH1A1 (0.75) ENPEPALDH1A1GPR84PPARGPPARD
SCHEMBL1881298 0.91 ALDH1A1 (0.75) ENPEPALDH1A1GPR84PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1380064-A Method for producing antibiotic preparation and its application HERAEUS GUSA GMBH & CO KG (DE) 2002-11-20 CN claimed
JP-2163083-A None JP disclosed
US-12404419-B2 Imide addition-fragmentation agents 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-09-02 US disclosed
US-12398301-B2 Adhesives comprising cyclic imide addition-fragmentation and adhesion agents 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-08-26 US disclosed
US-12329833-B2 Dental compositions SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2025-06-17 US disclosed
US-20250049644-A1 Dental Compositions SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2025-02-13 US disclosed
US-20250011633-A1 Adhesives Comprising Cyclic Imide Addition-Fragmentation And Adhesion Agents 3M INNOVATIVE PROPERTIES COMPANY 2025-01-09 US disclosed
EP-4444250-A1 DENTAL COMPOSITIONS Solventum Intellectual Properties Company (US) 2024-10-16 EP disclosed
EP-4444809-A1 ADHESIVES COMPRISING CYCLIC IMIDE ADDITION-FRAGMENTATION AND ADHESION AGENTS 3M Innovative Properties Company (US) 2024-10-16 EP disclosed
CN-118510482-A Dental composition 舒万诺知识产权公司 2024-08-16 CN disclosed
CN-1215404-A Non-dendritic backbone piptide carrier PEPRESEACH A S (DK) 1999-04-28 CN disclosed
US-5888971-A ANTICOAGULANT ORTHO PHARMACEUTICAL CORPORATION, INC. (US) 1999-03-30 US disclosed
WO-1998020036-A1 CONSTRAINED HELICAL PEPTIDES AND METHODS OF MAKING SAME GENENTECH, INC. (US) 1998-05-14 WO disclosed
WO-1997030080-A1 MACROCYCLIC PEPTIDES USEFUL IN THE TREATMENT OF THROMBIN RELATED DISORDERS ORTHO PHARMACEUTICAL CORPORATION (US) 1997-08-21 WO disclosed
US-4960702-A USING METAL CHELATE ADSORBER; SEPARATION CODON (US) 1990-10-02 US disclosed
JP-H02163083-A PRODUCTION OF HUMAN TISSUE TYPE PLASMINOGEN ACTIVATING FACTOR MITSUI TOATSU CHEM INC 1990-06-22 JP disclosed
WO-1989008702-A1 IMPROVED METHODS FOR RECOVERY OF TISSUE PLASMINOGEN ACTIVATOR USING CHAOTROPIC AGENTS CODON (US) 1989-09-21 WO disclosed
EP-0238551-A4 METHODS FOR THE RECOVERY OF TISSUE PLASMINOGEN ACTIVATOR. CODON (US) 1988-02-01 EP disclosed
EP-0238551-A1 METHODS FOR THE RECOVERY OF TISSUE PLASMINOGEN ACTIVATOR BERLEX LABORATORIES, INC. (US) 1987-09-30 EP disclosed
WO-1987001389-A1 METHODS FOR THE RECOVERY OF TISSUE PLASMINOGEN ACTIVATOR CODON (US) 1987-03-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250049644-A1 Dental Compositions ARCN1, EEF1D, EBP ENPEP 3112/4885ALDH1A1 1021/4885GABRP 590/4885
US-12329833-B2 Dental compositions ARCN1, EEF1D, EBP ENPEP 3112/4885ALDH1A1 1021/4885GABRP 590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.